ERT to offer ePRO solutions to pharma firms
ERT offers centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes ePRO in multiple modalities across all phases of clinical research.
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.